← FDA Drug Approvals (Drugs@FDA)

XELJANZ

NDA · New Drug Application · Sponsor: PF PRISM CV · Approved 2012-11-06

Drug application

FDA Application #

NDA203214

Application type

New Drug Application

Brand name

XELJANZ

Generic name

TOFACITINIB

Active ingredients

TOFACITINIB CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PF PRISM CV

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2012-11-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown